Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10192-1-AP - Provider product page

- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10192-1-AP, RRID:AB_2188183
- Product name
- ECD antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated ECD antibody (Cat. #10192-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IF, IP, WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Transcriptional regulation of Rankl by Txnip-Ecd in aging and diabetic related osteoporosis.
ECD, a novel androgen receptor target promotes prostate cancer tumorigenesis by regulating glycolysis.
ECD co-operates with ERBB2 to promote tumorigenesis through upregulation of unfolded protein response and glycolysis.
ECD functions as a novel RNA-binding protein to regulate mRNA splicing.
ECD co-operates with ERBB2 to promote tumorigenesis through upregulation of unfolded protein response and glycolysis.
ECD, a novel androgen receptor target promotes prostate cancer tumorigenesis by regulating glycolysis.
Amplification of ACK1 promotes gastric tumorigenesis via ECD-dependent p53 ubiquitination degradation.
Cao X, Liu K, Yuan J, Hua Q, Rong K, Zhou T, He W, Pang Y, Yang X, Yu Y, Zhang P, Ma P, Cao Y, Zhao J, Morahan G, Xu J, Qin A
Journal of advanced research 2025 Nov;77:221-234
Journal of advanced research 2025 Nov;77:221-234
ECD, a novel androgen receptor target promotes prostate cancer tumorigenesis by regulating glycolysis.
Raza M, Rajan AR, Kennedy BB, Reznicek TE, Oruji F, Mirza S, Rowley MJ, Stephan C, Kristiansen G, Datta K, Mohapatra BC, Band H, Band V
Oncogene 2025 Nov;44(42):4058-4074
Oncogene 2025 Nov;44(42):4058-4074
ECD co-operates with ERBB2 to promote tumorigenesis through upregulation of unfolded protein response and glycolysis.
Kennedy BB, Raza M, Mirza S, Rajan AR, Oruji F, Storck MM, Lele SM, Reznicek TE, Li L, Rowley MJ, Wan S, Mohapatra BC, Band H, Band V
Cancer letters 2025 Nov 1;632:217959
Cancer letters 2025 Nov 1;632:217959
ECD functions as a novel RNA-binding protein to regulate mRNA splicing.
Raza M, Rajan AR, Kalluchi A, Saleem I, Kennedy BB, Bhakat KK, Band H, Rowley MJ, Band V
bioRxiv : the preprint server for biology 2025 May 27;
bioRxiv : the preprint server for biology 2025 May 27;
ECD co-operates with ERBB2 to promote tumorigenesis through upregulation of unfolded protein response and glycolysis.
Kennedy BB, Raza M, Mirza S, Rajan AR, Oruji F, Storck MM, Lele SM, Reznicek TE, Li L, Rowley MJ, Wan S, Mohapatra BC, Band H, Band V
bioRxiv : the preprint server for biology 2025 Feb 1;
bioRxiv : the preprint server for biology 2025 Feb 1;
ECD, a novel androgen receptor target promotes prostate cancer tumorigenesis by regulating glycolysis.
Raza M, Rajan AR, Kennedy BB, Reznicek TE, Oruji F, Mirza S, Rowley MJ, Stephan C, Kristiansen G, Datta K, Mohapatra BC, Band H, Band V
bioRxiv : the preprint server for biology 2025 Aug 7;
bioRxiv : the preprint server for biology 2025 Aug 7;
Amplification of ACK1 promotes gastric tumorigenesis via ECD-dependent p53 ubiquitination degradation.
Xu SH, Huang JZ, Chen M, Zeng M, Zou FY, Chen D, Yan GR
Oncotarget 2017 Feb 21;8(8):12705-12716
Oncotarget 2017 Feb 21;8(8):12705-12716
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- The ECD antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human ECD. This antibody recognizes human, mouse antigen. The ECD antibody has been validated for the following applications: ELISA, WB analysis.